Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway. [electronic resource]
- Biomaterials 02 2020
- 119730 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1878-5905
10.1016/j.biomaterials.2019.119730 doi
Animals Arthritis, Experimental--drug therapy Arthritis, Rheumatoid--drug therapy Carrier Proteins Dexamethasone Mice Nanoparticles Reactive Oxygen Species Signal Transduction Tumor Necrosis Factor-alpha--metabolism